What is the role of bevacizumab in the treatment of fallopian tube carcinoma?

Updated: Aug 20, 2019
  • Author: from Memorial Sloan-Kettering - Elizabeth L Jewell, MD, MHSc; Chief Editor: from Memorial Sloan-Kettering - Yukio Sonoda, MD  more...
  • Print


Antiangiogenic agents (eg, bevacizumab) may be beneficial in front-line therapy, maintenance, or recurrent disease and are being explored in ongoing studies. [23, 17]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!